Abstract
The dopaminergic system has key roles in human physiology and is implicated in a broad range of neurological and neuropsychiatric conditions that are increasingly investigated using induced pluripotent stem cell-derived midbrain models. To determine similarities of such models to human systems, here we undertake single-cell and spatial profiling of first and second trimester fetal midbrain and compare it to in vitro midbrain models. Histological examination reveals that, by the second trimester, fetal midbrain tissue exhibits structural complexity comparable to that of adults. At the molecular level, single-cell profiling uncovers differences in cellular composition across models, with brain organoids most closely resembling late first trimester tissue — an observation supported by meta-integration of existing midbrain datasets. By reconstructing developmental trajectories of neuronal and astrocytic lineages, we map gene expression dynamics associated with maturation. Importantly, integration of spatial transcriptomics provides critical context for aligning organoid models, revealing that their spatial organization and intercellular signaling resemble the architecture and microenvironment of the second trimester midbrain. Ultimately, we leverage our findings to study Dopamine Transporter Deficiency Syndrome progression in patient-derived midbrain organoids, validating their relevance. Understanding the extent of human tissue recapitulation in midbrain laboratory models is essential to justify their use as biological proxies.
Data availability
Raw FASTQ files for both single-cell and spatial transcriptomics generated in this study have been deposited in Gene Expression Omnibus (GEO) under accession code GSE277032, accessible at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277032. The four supplemental data files generated in this study are available in a Zenodo repository (https://zenodo.org/records/13765496), detailed as follows: Files S1, S2: VCF files with donor genotypes to deconvolute pooled scRNA-seq data. File S3: Single-cell data generated in our study (RDS object: Seurat object with counts and metadata). File S4: Integrated datasets (RDS object: Seurat object with counts and metadata). Additionally, the images from the immunohistochemistry analysis on midbrain tissues are available in the MRC-Wellcome Trust Human Developmental Biology Resource (HDBR) Atlas (https://hdbratlas.org/gene-expression/midbrain.html). Source data for graphs and tables are included with the manuscript. Source data are provided with this paper.
Code availability
Two GitHub repositories are available for reproducing the analysis and figures of the manuscript: one for single-cell transcriptomics (https://github.com/paupuigdevall/MLOscRNAseq, archived at https://doi.org/10.5281/zenodo.17541380) and another for spatial transcriptomics (https://github.com/george-hall-ucl/mlo_spatial_transcriptomics, archived at https://doi.org/10.5281/zenodo.17550243). These repositories include scripts for processing steps, data analysis and figure generation. Additionally, the Docker images used for spatial transcriptomics are available on Dockerhub (main pipeline: georgehallucl/midbrain_tissues_organoids_docker; commot: georgehallucl/commot_docker; cell2location: georgehallucl/cell2location_docker). An archive to reproduce the spatial transcriptomics analysis is available at https://doi.org/10.5522/04/27044423.
References
Parraga, R. G. et al. Microsurgical anatomy and internal architecture of the brainstem in 3D images: surgical considerations. J. Neurosurg. 124, 1377–1395 (2016).
Faissner, A. Low-density lipoprotein receptor-related protein-1 (LRP1) in the glial lineage modulates neuronal excitability. Front. Netw. Physiol. 3, 1190240 (2023).
Garritsen, O., van Battum, E. Y., Grossouw, L. M. & Pasterkamp, R. J. Development, wiring and function of dopamine neuron subtypes. Nat. Rev. Neurosci. 24, 134–152 (2023).
Bissonette, G. B. & Roesch, M. R. Development and function of the midbrain dopamine system: what we know and what we need to. Genes Brain Behav. 15, 62–73 (2016).
Kurian, M. A., Gissen, P., Smith, M., Heales, S. Jr. & Clayton, P. T. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol. 10, 721–733 (2011).
La Manno, G. et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167, 566–580 e519 (2016).
Birtele, M. et al. Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain. Development 149, dev200504 (2022).
Zagare, A. et al. Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. Am. J. Hum. Genet. 109, 311–327 (2022).
Nelander, J., Hebsgaard, J. B. & Parmar, M. Organization of the human embryonic ventral mesencephalon. Gene Expr. Patterns 9, 555–561 (2009).
Li, Y. et al. Spatiotemporal transcriptome atlas reveals the regional specification of the developing human brain. Cell 186, 5892–5909 e5822 (2023).
Braun, E. et al. Comprehensive cell atlas of the first-trimester developing human brain. Science 382, eadf1226 (2023).
Siletti, K. et al. Transcriptomic diversity of cell types across the adult human brain. Science 382, eadd7046 (2023).
Eze, U. C., Bhaduri, A., Haeussler, M., Nowakowski, T. J. & Kriegstein, A. R. Single-cell atlas of early human brain development highlights heterogeneity of human neuroepithelial cells and early radial glia. Nat. Neurosci. 24, 584–594 (2021).
Yu, Y. et al. Interneuron origin and molecular diversity in the human fetal brain. Nat. Neurosci. 24, 1745–1756 (2021).
Barral, S. & Kurian, M. A. Utility of induced pluripotent stem cells for the study and treatment of genetic diseases: focus on childhood neurological disorders. Front. Mol. Neurosci. 9, 78 (2016).
Gantner, C. W., Cota-Coronado, A., Thompson, L. H. & Parish, C. L. An optimized protocol for the generation of midbrain dopamine neurons under defined conditions. STAR Protoc. 1, 100065 (2020).
Carola, G. et al. Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration. NPJ Parkinsons Dis. 7, 55 (2021).
Fiorenzano, A. et al. Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids. Nat. Commun. 12, 7302 (2021).
Jo, J. et al. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. Cell Stem Cell 19, 248–257 (2016).
Nickels, S. L. et al. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson’s disease. Stem Cell Res. 46, 101870 (2020).
Marklund, U. et al. Detailed expression analysis of regulatory genes in the early developing human neural tube. Stem Cells Dev. 23, 5–15 (2014).
Tiklova, K. et al. Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development. Nat. Commun. 10, 581 (2019).
Almqvist, P. M. et al. First trimester development of the human nigrostriatal dopamine system. Exp. Neurol. 139, 227–237 (1996).
Ferri, A. L. et al. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 134, 2761–2769 (2007).
Andersson, E. et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124, 393–405 (2006).
Asgrimsdottir, E. S. & Arenas, E. Midbrain dopaminergic neuron development at the single cell level: in vivo and in stem cells. Front. Cell Dev. Biol. 8, 463 (2020).
Waldvogel, H. J., Curtis, M. A., Baer, K., Rees, M. I. & Faull, R. L. Immunohistochemical staining of post-mortem adult human brain sections. Nat. Protoc. 1, 2719–2732 (2006).
Hegarty, S. V., Sullivan, A. M. & O’Keeffe, G. W. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Dev. Biol. 379, 123–138 (2013).
Reyes, S. et al. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. J. Comp. Neurol. 520, 2591–2607 (2012).
Di Salvio, M., Di Giovannantonio, L. G., Omodei, D., Acampora, D. & Simeone, A. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain. Int J. Dev. Biol. 54, 939–945 (2010).
Arenas, E., Denham, M. & Villaescusa, J. C. How to make a midbrain dopaminergic neuron. Development 142, 1918–1936 (2015).
Hanaway, J., McConnell, J. A. & Netsky, M. G. Histogenesis of the substantia nigra, ventral tegmental area of Tsai and interpeduncular nucleus: an autoradiographic study of the mesencephalon in the rat. J. Comp. Neurol. 142, 59–73 (1971).
Kawano, H., Ohyama, K., Kawamura, K. & Nagatsu, I. Migration of dopaminergic neurons in the embryonic mesencephalon of mice. Brain Res. Dev. Brain Res. 86, 101–113 (1995).
Gupta, D. Neuroanatomy. in Essentials of Neuroanesthesia (ed. Prabhakar, H.) 3–40 (Academic Press, 2017).
Johns, P. Functional neuroanatomy. in Clinical Neuroscience 27–47 (Churchill Livingstone/Elsevier, 2014).
Ng, J. et al. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile Parkinsonism. Sci. Transl. Med. 13, eaaw1564 (2021).
Kirkeby, A. et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 1, 703–714 (2012).
Abela, L. et al. Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy. Brain 147, 2023–2037 (2024).
Monzel, A. S. et al. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Rep. 8, 1144–1154 (2017).
Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).
Kang, H. M. et al. Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat. Biotechnol. 36, 89–94 (2018).
Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293–304 (2024).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Funk, M. C. et al. Cyclin O (Ccno) functions during deuterosome-mediated centriole amplification of multiciliated cells. EMBO J. 34, 1078–1089 (2015).
Ricard-Blum, S. The collagen family. Cold Spring Harb. Perspect. Biol. 3, a004978 (2011).
Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245–253 (2022).
Caporale, N. et al. Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single-cell resolution. Nat. Methods 22, 358–370 (2025).
Van den Berge, K. et al. Trajectory-based differential expression analysis for single-cell sequencing data. Nat. Commun. 11, 1201 (2020).
Agarwal, D. et al. A single-cell atlas of the human substantia nigra reveals cell-specific pathways associated with neurological disorders. Nat. Commun. 11, 4183 (2020).
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).
Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241–1243 (2016).
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
Kolberg, L. et al. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 51, W207–W212 (2023).
Cable, D. M. et al. Cell type-specific inference of differential expression in spatial transcriptomics. Nat. Methods 19, 1076–1087 (2022).
Roll, S., Seul, J., Paulsson, M. & Hartmann, U. Testican-1 is dispensable for mouse development. Matrix Biol. 25, 373–381 (2006).
Vadasz, C. et al. Mesencephalic dopamine neuron number and tyrosine hydroxylase content: genetic control and candidate genes. Neuroscience 149, 561–572 (2007).
Novak, G. et al. Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease. Commun. Biol. 5, 49 (2022).
Maffezzini, C., Calvo-Garrido, J., Wredenberg, A. & Freyer, C. Metabolic regulation of neurodifferentiation in the adult brain. Cell Mol. Life Sci. 77, 2483–2496 (2020).
Traxler, L. et al. Metabolism navigates neural cell fate in development, aging and neurodegeneration. Dis. Model. Mech. 14, dmm048993 (2021).
Elkjaer, M. L. et al. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis. Acta Neuropathol. Commun. 7, 205 (2019).
Dou, D. & Joseph, R. Structure and organization of the human neuronatin gene. Genomics 33, 292–297 (1996).
Ren, S. et al. Lissencephaly caused by a de novo mutation in tubulin TUBA1A: a case report and literature review. Front. Pediatr. 12, 1367305 (2024).
Granger, A. J., Wallace, M. L. & Sabatini, B. L. Multi-transmitter neurons in the mammalian central nervous system. Curr. Opin. Neurobiol. 45, 85–91 (2017).
Yao, J. J., Zhao, Q. R., Lu, J. M. & Mei, Y. A. Functions and the related signaling pathways of the neurotrophic factor neuritin. Acta Pharm. Sin. 39, 1414–1420 (2018).
Chen, J., Ding, Q., An, L. & Wang, H. Ca(2 + )-stimulated adenylyl cyclases as therapeutic targets for psychiatric and neurodevelopmental disorders. Front. Pharm. 13, 949384 (2022).
Cang, Z. et al. Screening cell-cell communication in spatial transcriptomics via collective optimal transport. Nat. Methods 20, 218–228 (2023).
Jung, C. G. et al. Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. FASEB J. 18, 1237–1239 (2004).
Mourlevat, S. et al. Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons: analysis of suppression-subtracted cDNA libraries and confirmation in vitro. Exp. Neurol. 194, 243–254 (2005).
Bloch, B., Normand, E., Kovesdi, I. & Bohlen, P. Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study. Brain Res. Dev. Brain Res. 70, 267–278 (1992).
Winkler, C. & Yao, S. The midkine family of growth factors: diverse roles in nervous system formation and maintenance. Br. J. Pharm. 171, 905–912 (2014).
Fujikawa, A. et al. Mice deficient in protein tyrosine phosphatase receptor type Z (PTPRZ) show reduced responsivity to methamphetamine despite an enhanced response to novelty. PLoS One 14, e0221205 (2019).
Lodato, S. & Arlotta, P. Generating neuronal diversity in the mammalian cerebral cortex. Annu. Rev. Cell Dev. Biol. 31, 699–720 (2015).
Kurian, M. A. et al. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 10, 54–62 (2011).
Caminero, F. & Cascella, M. Neuroanatomy, mesencephalon midbrain. in StatPearls [Internet] (StatPearls Publishing, 2022).
Bodea, G. O. et al. Reelin and CXCL12 regulate distinct migratory behaviors during the development of the dopaminergic system. Development 141, 661–673 (2014).
Vaswani, A. R. et al. Correct setup of the substantia nigra requires Reelin-mediated fast, laterally-directed migration of dopaminergic neurons. Elife 8, e41623 (2019).
Williams, C. G., Lee, H. J., Asatsuma, T., Vento-Tormo, R. & Haque, A. An introduction to spatial transcriptomics for biomedical research. Genome Med. 14, 68 (2022).
Zampese, E. et al. Ca(2 + ) channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons. Sci. Adv. 8, eabp8701 (2022).
Ni, A. & Ernst, C. Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active. Front. Cell Neurosci. 16, 826193 (2022).
Norat, P. et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen. Med. 5, 22 (2020).
Prasuhn, J., Davis, R. L. & Kumar, K. R. Targeting mitochondrial impairment in Parkinson’s disease: challenges and opportunities. Front. Cell Dev. Biol. 8, 615461 (2020).
Tekin, H. et al. Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons. Nat. Biomed. Eng. 2, 540–554 (2018).
Quadrato, G. et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545, 48–53 (2017).
Gillen, A. E. et al. Alternative polyadenylation of PRELID1 regulates mitochondrial ROS signaling and cancer outcomes. Mol. Cancer Res. 15, 1741–1751 (2017).
Green, D. R. Apoptotic pathways: ten minutes to dead. Cell 121, 671–674 (2005).
Ng, M. Y. W., Wai, T. & Simonsen, A. Quality control of the mitochondrion. Dev. Cell 56, 881–905 (2021).
Rossignoli, G. et al. Aromatic l-amino acid decarboxylase deficiency: a patient-derived neuronal model for precision therapies. Brain 144, 2443–2456 (2021).
Gene Ontology, C. et al. The Gene Ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).
Falcon, S. & Gentleman, R. Using GOstats to test gene lists for GO term association. Bioinformatics 23, 257–258 (2007).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 e3529 (2021).
Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661–671 (2022).
Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).
Moran, P. A. Notes on continuous stochastic phenomena. Biometrika 37, 17–23 (1950).
Acknowledgements
We sincerely thank our patients and their families for participating in this study. D.B. was supported by the Sir Jules Thorn Trust. P.P.C. and H.K. are currently funded by the Sigrid Jusélius Foundation and previously by the NIHR Great Ormond Street Hospital Biomedical Research Centre. G.T.H. is funded by the NIHR Great Ormond Street Hospital Biomedical Research Centre. J.J. was supported by a postdoctoral fellowship from OpenTargets. F.P. is supported by the UK Medical Research Council (MRC) [UKRI222 – PI S.B.]. M.A.K. is supported by the NIHR Professorship, the Sir Jules Thorn Award for Biomedical Research and the Rosetrees Trust. S.B. was supported by the Great Ormond Street Hospital Children’s Charity. We thank UCL Genomics (UCL GOS Institute of Child Health) and the Wellcome Sanger Institute for undertaking scRNA and spatial sequencing. We thank the Human Developmental Biology Resource (HDBR) for providing human midbrain fetal tissue. We thank the UCL Imaging Facility and the facility manager, Dr Dale Moulding, for the support with immunofluorescence analysis. This research was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Graphical schemes have been created in BioRender. https://BioRender.com/.
Author information
Authors and Affiliations
Contributions
D.B., S.B., and M.A.K. conceived and designed the study. S.B. designed and performed experiments and data analysis for the in vitro and in vivo study. D.B. designed and performed experiments and data analysis for the in vitro and in vivo study. P.P.C. designed and performed data analysis for the scRNA-seq study. G.T.H. designed and performed data analysis for the spatial transcriptomic study. C.R. performed experiments for the in vitro study. T.X. designed and performed experiments for the scRNA-seq and spatial transcriptomic studies. E.M. performed experiments for the spatial transcriptomics study. J.J. performed experiments for the scRNA-seq study. A.D.D. performed experiments for the in vitro study. F.P. performed experiments for the in vivo study. H.K. supervised the scRNA-seq study. S.C. supervised scRNA-seq and spatial transcriptomic studies. D.B., P.P.C., G.T.H., S.C., S.B., and M.A.K. drafted the manuscript. C.R. and T.X. contributed to the written sections of the manuscript. All authors reviewed the manuscript prior to submission.
Corresponding authors
Ethics declarations
Competing interests
M.A.K. is a founder of and consultant to Bloomsbury Genetic Therapies. She has received honoraria from PTC for sponsored symposia and provided consultancy. The remaining authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Budinger, D., Puigdevall, P., Hall, G.T. et al. An in vivo and in vitro spatiotemporal profile of human midbrain development. Nat Commun (2026). https://doi.org/10.1038/s41467-025-67779-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-025-67779-1